Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 13 | 1 | 12 | -5 | 58 |
| Other Working Capital | 75 | 394 | 137 | -3 | -2 |
| Other Operating Activity | -94 | -469 | -367 | -462 | -332 |
| Operating Cash Flow | $-6 | $-74 | $-218 | $-470 | $-276 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | 0 | 0 | 0 | -30 | N/A |
| Investing Cash Flow | $0 | $0 | $0 | $-30 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -26 | 65 | 0 | 26 | 39 |
| Debt Repayment | 0 | 0 | 0 | -26 | -79 |
| Financing Cash Flow | $-26 | $65 | $0 | $0 | $-40 |
| Beginning Cash Position | 46 | 55 | 273 | 773 | 1,049 |
| End Cash Position | 15 | 46 | 55 | 273 | 773 |
| Net Cash Flow | $-32 | $-9 | $-218 | $-500 | $-276 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6 | -74 | -218 | -470 | -276 |
| Free Cash Flow | -6 | -74 | -218 | -470 | -276 |